Figure 6.
The clinical outcomes of high Serpinc1 gene expression in public databases. (A) Comparisons of Serpinc1 gene expression in normal (n = 391), tumor (n = 1,865), and metastatic tissues (n = 8) in lung cancer patients using one-way ANOVA followed by Dunnett’s multiple comparisons. Kaplan–Meier survival analysis of OS according to Serpinc1 expression level in (B) lung cancer patients (n = 2,437), (C) lung adenocarcinoma patients (n = 719), and (D) lung squamous cell carcinoma patients (n = 524).